- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01148082
School Response to Families Who Have Children With Cancer
June 22, 2017 updated by: Stanford University
The purpose of this research is to investigate school response to families who have children with cancer.
It is anticipated that the results of this study will enhance the support that schools can give to the population of families who have a child with cancer.
The study will involve the parents in these families, the principal and an educator in the school of the child with cancer.
Measurement tools will include surveys, interviews, and other relevant educational and medical documents.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Prospective participants will be parents/caregivers who have had school-age children treated for cancer within the last 5 years
Description
Inclusion Criteria:
- Patients will not be recruited. Only parents, the school principals and the teachers will be recruited.
- Subjects will be 15 sets of parents who have had school-age children treated for cancer within the last 5 years.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evidence of support
Time Frame: one time
|
Identify significant patterns.
Documents, interview, surveys and the quantitative instrument will be analyzed with an inductive cross-case analysis.
Inductive analysis means that the patterns, themes, and categories emerged out of the data rather than being imposed on them prior to data collection and analysis.
A cross-case analysis means that the information will be grouped together according to answers from different people, themes, perspectives or issues.
Then, a content analysis will be conducted which includes the process of identifying, coding, and categorizing the primary patterns in the data.
In the final step, the data will be interpreted.
Interpretation, by definition, goes beyond description.
Interpretation means attaching significance to what was found offering explanations, drawing conclusions, making inferences, building linkages, attaching meaning, imposing order and dealing with rival explanations
|
one time
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Link, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2010
Primary Completion (Anticipated)
July 1, 2011
Study Completion (Anticipated)
July 1, 2011
Study Registration Dates
First Submitted
June 18, 2010
First Submitted That Met QC Criteria
June 18, 2010
First Posted (Estimate)
June 22, 2010
Study Record Updates
Last Update Posted (Actual)
June 26, 2017
Last Update Submitted That Met QC Criteria
June 22, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEDSVAR0010
- 17105 (Stanford IRB)
- SU-09112009-3880 (Other Identifier: Stanford University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.